Abbott agrees to expand access to Kaletra/Aluvia.
D003363:Cost Control; D003906:Developing Countries; D004338:Drug Combinations; D004345:Drug Industry; D017320:HIV Protease Inhibitors / Q000191:economics*; D006801:Humans; D007391:International Cooperation; D061466:Lopinavir; D011744:Pyrimidinones / Q000191:economics*; D019438:Ritonavir / Q000191:economics*
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir